If confirmed in a larger set, this may be significant in terms of therapeutic decision-making, as these mutations often predict resistance to standard therapies and may guide the use of targeted or experimental treatments [ 19 , 24 , 33 ].
← all excerpts
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype.
1
—
—